Silence Therapeutics Announces Retirement of Alistair Gray from Board of Directors

Contributed by: Business Wire

Logo

Tags

Biotechnology

Pharmaceutical

Genetics

Health

Silence Therapeutics plc

More Like This

Silence Therapeutics to Present at Jefferies London Healthcare Conference

Silence Therapeutics to Participate in Fireside Chat at Guggenheim Healthcare Talks 6th Annual Biotechnology Conference

Silence Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights

Silence Therapeutics to Present at Jefferies Global Healthcare Conference

Silence Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights

Silence Therapeutics to Webcast Presentations at Upcoming September Investor Conferences

Silence Therapeutics to Participate in Fireside Chat at H.C. Wainwright 2nd Annual BioConnect Investor Conference

Silence Therapeutics to Report Fourth Quarter and Full Year 2023 Results on March 13, 2024